Histiocytic Disorders, Malignant
"Histiocytic Disorders, Malignant" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Distinctive neoplastic disorders of histiocytes. Included are malignant neoplasms of MACROPHAGES and DENDRITIC CELLS.
MeSH Number(s)
C04.557.227
C15.604.250.390
Concept/Terms
Histiocytic Disorders, Malignant- Histiocytic Disorders, Malignant
- Disorder, Malignant Histiocytic
- Disorders, Malignant Histiocytic
- Histiocytic Disorder, Malignant
- Malignant Histiocytic Disorder
- Malignant Histiocytic Disorders
Below are MeSH descriptors whose meaning is more general than "Histiocytic Disorders, Malignant".
Below are MeSH descriptors whose meaning is more specific than "Histiocytic Disorders, Malignant".
This graph shows the total number of publications written about "Histiocytic Disorders, Malignant" by people in Harvard Catalyst Profiles by year, and whether "Histiocytic Disorders, Malignant" was a major or minor topic of these publication.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2002 | 1 | 0 | 1 |
| 2006 | 1 | 0 | 1 |
| 2010 | 1 | 0 | 1 |
| 2016 | 1 | 0 | 1 |
| 2018 | 1 | 0 | 1 |
| 2022 | 1 | 0 | 1 |
Below are the most recent publications written about "Histiocytic Disorders, Malignant" by people in Profiles.
-
ALK-positive histiocytosis: a new clinicopathologic spectrum highlighting neurologic involvement and responses to ALK inhibition. Blood. 2022 01 13; 139(2):256-280.
-
Expression of enhancer of zeste homolog 2 (EZH2) protein in histiocytic and dendritic cell neoplasms with evidence for p-ERK1/2-related, but not MYC- or p-STAT3-related cell signaling. Mod Pathol. 2018 04; 31(4):553-561.
-
Clonal reticulohistiocytosis of the skin and bone marrow associated with systemic mastocytosis and acute myeloid leukaemia. Histopathology. 2017 May; 70(6):1000-1008.
-
Revised classification of histiocytoses and neoplasms of the macrophage-dendritic cell lineages. Blood. 2016 06 02; 127(22):2672-81.
-
The phosphatidylserine receptors, T cell immunoglobulin mucin proteins 3 and 4, are markers of histiocytic sarcoma and other histiocytic and dendritic cell neoplasms. Hum Pathol. 2010 Oct; 41(10):1486-94.
-
The PTEN and INK4A/ARF tumor suppressors maintain myelolymphoid homeostasis and cooperate to constrain histiocytic sarcoma development in humans. Cancer Cell. 2006 May; 9(5):379-90.
-
Tumours of histiocytes and accessory dendritic cells: an immunohistochemical approach to classification from the International Lymphoma Study Group based on 61 cases. Histopathology. 2002 Jul; 41(1):1-29.
-
Targeting of transgene expression to monocytes by cytochrome b heavy chain gene 5'-flanking sequences induces histiocytic malignancies. Trans Assoc Am Physicians. 1990; 103:129-36.